Spark Investment Management LLC Sage Therapeutics, Inc. Transaction History

Spark Investment Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$70.65 - $96.76 $226,080 - $309,632	-3,200 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$58.41 - $89.06 $186,912 - $284,992	3,200 New	3,200 $276,000
Q2 2020 Aug 12, 2020	SELL	$25.95 - $43.15 $487,860 - $811,220	-18,800 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$26.15 - $77.24 $491,620 - $1.45 Million	18,800 New	18,800 $539,000
Q3 2019 Nov 12, 2019	SELL	$140.29 - $189.96 $3.91 Million - $5.3 Million	-27,900 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$157.85 - $183.09 $4.4 Million - $5.11 Million	27,900 New	27,900 $5.11 Million
Q1 2019 May 07, 2019	SELL	$89.33 - $163.65 $1.37 Million - $2.5 Million	-15,300 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$81.94 - $139.71 $680,102 - $1.16 Million	8,300 Added 118.57%	15,300 $1.47 Million
Q3 2018 Nov 13, 2018	BUY	$138.11 - $169.04 $966,770 - $1.18 Million	7,000 New	7,000 $988,000
Q4 2017 Feb 12, 2018	SELL	$60.72 - $167.34 $4.24 Million - $11.7 Million	-69,900 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$61.4 - $88.52 $4.29 Million - $6.19 Million	69,900	69,900 $4.35 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.